HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 206 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $83,859,672 | +24.8% | 1,601,598 | -3.0% | 0.02% | +25.0% |
| Q1 2024 | $67,187,839 | +19.2% | 1,651,610 | +8.3% | 0.02% | +11.1% |
| Q4 2023 | $56,371,465 | -4.5% | 1,525,202 | -1.3% | 0.02% | -14.3% |
| Q3 2023 | $59,013,118 | +20.1% | 1,544,846 | +13.4% | 0.02% | +23.5% |
| Q2 2023 | $49,152,769 | +104152.1% | 1,362,705 | +10.4% | 0.02% | -5.6% |
| Q1 2023 | $47,148 | -16.8% | 1,234,558 | +24.0% | 0.02% | -18.2% |
| Q4 2022 | $56,645 | -99.9% | 995,536 | -3.9% | 0.02% | +29.4% |
| Q3 2022 | $40,945,000 | -8.3% | 1,035,523 | +2.0% | 0.02% | 0.0% |
| Q2 2022 | $44,650,000 | +24.9% | 1,014,796 | +5.6% | 0.02% | +41.7% |
| Q1 2022 | $35,761,000 | -8.3% | 961,334 | -0.9% | 0.01% | 0.0% |
| Q4 2021 | $39,016,000 | -5.2% | 970,318 | -4.1% | 0.01% | -7.7% |
| Q3 2021 | $41,161,000 | -1.3% | 1,011,808 | +10.2% | 0.01% | +8.3% |
| Q2 2021 | $41,703,000 | +12.2% | 918,352 | +3.0% | 0.01% | 0.0% |
| Q1 2021 | $37,166,000 | -14.3% | 891,506 | -12.2% | 0.01% | -20.0% |
| Q4 2020 | $43,381,000 | +58.8% | 1,015,711 | -2.3% | 0.02% | +36.4% |
| Q3 2020 | $27,321,000 | -0.8% | 1,039,620 | +1.2% | 0.01% | 0.0% |
| Q2 2020 | $27,549,000 | +40.1% | 1,027,577 | -6.0% | 0.01% | +10.0% |
| Q1 2020 | $19,661,000 | -22.3% | 1,092,902 | -23.4% | 0.01% | 0.0% |
| Q4 2019 | $25,306,000 | +28.9% | 1,427,325 | +12.8% | 0.01% | +25.0% |
| Q3 2019 | $19,625,000 | -23.1% | 1,265,341 | -14.9% | 0.01% | -20.0% |
| Q2 2019 | $25,530,000 | +6514.0% | 1,486,081 | +6394.3% | 0.01% | +400.0% |
| Q2 2018 | $386,000 | -17.3% | 22,883 | -4.0% | 0.00% | -33.3% |
| Q1 2018 | $467,000 | -3.3% | 23,846 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $483,000 | – | 23,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
| BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
| QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
| Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
| SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
| Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
| HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
| Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
| Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |